Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed-cisplatin with or without Avastin in malignant pleural mesothelioma
2007-002574-63Phase 2Completed
- Sponsor
- CHU Caen Normandie
- Start
- Jun 2007
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in pleural mesothelioma comparing Pemetrexed + cisplatin with Pemetrexed + cisplatin + Avastin (2 arms). Started Jun 2007; status: completed.
02
Drugs
bevacizumabpemetrexedcisplatin
03
Conditions
pleural mesothelioma
Beyond the preview
Go deeper on 2007-002574-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002574-63.